Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IRBIT coordinates epithelial fluid and HCO3– secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct
Dongki Yang, … , Katsuhiko Mikoshiba, Shmuel Muallem
Dongki Yang, … , Katsuhiko Mikoshiba, Shmuel Muallem
Published December 1, 2008
Citation Information: J Clin Invest. 2009;119(1):193-202. https://doi.org/10.1172/JCI36983.
View: Text | PDF
Research Article

IRBIT coordinates epithelial fluid and HCO3– secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct

  • Text
  • PDF
Abstract

Fluid and HCO3– secretion are vital functions of secretory epithelia. In most epithelia, this entails HCO3– entry at the basolateral membrane, mediated by the Na+-HCO3– cotransporter, pNBC1, and exit at the luminal membrane, mediated by a CFTR-SLC26 transporters complex. Here we report that the protein IRBIT (inositol-1,4,5-trisphosphate [IP3] receptors binding protein released with IP3), a previously identified activator of pNBC1, activates both the basolateral pNBC1 and the luminal CFTR to coordinate fluid and HCO3– secretion by the pancreatic duct. We used video microscopy and ion selective microelectrodes to measure fluid secretion and Cl– and HCO3– concentrations in cultured murine sealed intralobular pancreatic ducts. Short interference RNA–mediated knockdown of IRBIT markedly inhibited ductal pNBC1 and CFTR activities, luminal Cl– absorption and HCO3– secretion, and the associated fluid secretion. Single-channel measurements suggested that IRBIT regulated CFTR by reducing channel mean close time. Furthermore, expression of IRBIT constructs in HEK cells revealed that activation of pNBC1 required only the IRBIT PEST domain, while activation of CFTR required multiple IRBIT domains, suggesting that IRBIT activates these transporters by different mechanisms. These findings define IRBIT as a key coordinator of epithelial fluid and HCO3– secretion and may have implications to all CFTR-expressing epithelia and to cystic fibrosis.

Authors

Dongki Yang, Nikolay Shcheynikov, Weizhong Zeng, Ehud Ohana, Insuk So, Hideaki Ando, Akihiro Mizutani, Katsuhiko Mikoshiba, Shmuel Muallem

×

Figure 4

IRBIT stimulates pancreatic duct pNBC1 and CFTR activity.

Options: View larger image (or click on image) Download as PowerPoint
IRBIT stimulates pancreatic duct pNBC1 and CFTR activity.
(A) Measuremen...
(A) Measurement of pHi in ducts treated with scrambled (left traces) or IRBIT siRNA (right traces) and perfused with HEPES-buffered media is shown. Where indicated the ducts were exposed to media in which 20 mM NH4Cl replaced 20 mM NaCl, with and without 100 μM bumetanide, as indicated. The inhibition of pHi recovery by bumetanide is given in B in the form of ΔpH/min (mean ± SEM). (C) All solutions contained 10 μM S-(N-ethyl-N-isopropyl) amiloride (EIPA). Ducts treated with scrambled (black trace) or IRBIT siRNA (red trace) in HEPES-buffered media were perfused with Na+-free HCO3–-buffered media. After completion of the acidification, the ducts were perfused with media containing 140 mM Na+ and then were perfused again with Na+-free media to reacidify the ducts. The ducts were used to measure recovery from acidification in the presence of the pNBC1 inhibitor 0.2 mM H2DIDS. The rates of Na+-dependent and H2DIDS-inhibitable changes in pHi reflect pNBC1 activity and are summarized in D. The results are given as mean ± SEM of 4 experiments. (E) The changes in MQAE fluorescence of ducts treated with scrambled (black trace) or IRBIT siRNA (red trace) and perfused in HEPES-buffered media are shown. Where indicated, the ducts were stimulated with forskolin and then perfused with media, in which all Cl– was replaced with NO3–. The dashed lines mark the largest slopes. (F) Summary (mean ± SEM) of increase in MQAE fluorescence, as in E. Numbers within bars denote number of experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts